4//SEC Filing
Silva Francisco 4
Accession 0001567619-22-018424
CIK 0001505497other
Filed
Oct 11, 8:00 PM ET
Accepted
Oct 12, 8:54 AM ET
Size
19.9 KB
Accession
0001567619-22-018424
Insider Transaction Report
Form 4
Silva Francisco
VP of Research and Development
Transactions
- Purchase
Common Stock
2022-10-11$3.69/sh+806$2,973→ 164,378 total
Holdings
- 1
Stock Option
Exercise: $3000.00Exp: 2022-12-07→ Common Stock (1 underlying) - 9
Stock Option
Exercise: $3000.00Exp: 2024-10-23→ Common Stock (9 underlying) - 15
Stock Option
Exercise: $3000.00Exp: 2026-06-10→ Common Stock (15 underlying) - 3
Stock Option
Exercise: $3000.00Exp: 2024-02-18→ Common Stock (3 underlying) - 293,479
Stock Option
Exercise: $13.50Exp: 2031-03-18→ Common Stock (293,479 underlying) - 42,059
Stock Option
Exercise: $13.50Exp: 2031-11-04→ Common Stock (42,059 underlying) - 1
Stock Option
Exercise: $3000.00Exp: 2023-10-04→ Common Stock (1 underlying) - 1
Stock Option
Exercise: $3000.00From: 2014-03-12Exp: 2024-03-11→ Common Stock (1 underlying) - 6
Stock Option
Exercise: $3000.00Exp: 2025-09-04→ Common Stock (6 underlying) - 12,136(indirect: By IRA)
Common Stock
- 20
Stock Option
Exercise: $3000.00Exp: 2027-07-12→ Common Stock (20 underlying) - 25
Stock Option
Exercise: $3000.00Exp: 2028-10-29→ Common Stock (25 underlying)
Footnotes (5)
- [F1]This transaction was executed in multiple trades at prices ranging from $3.68 to $3.70 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.
- [F2]Includes 104,045 shares received pursuant to unvested restricted stock unit grants. Such shares vest to the extent of 1,037 shares on each of October 18, 2022, December 18, 2022 and February 18, 2023, 1,036 shares on each of November 18, 2022 and January 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024.
- [F3]The option is currently exercisable.
- [F4]The option vests and becomes exercisable to the extent of 146,740 shares on March 18, 2021, 36,684 shares on November 4, 2021 and the remaining 110,055 shares in six nearly equal quarterly installments beginning December 18, 2021 and continuing every three months thereafter until fully vested.
- [F5]The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 with the remaining 21,029 shares vesting quarterly in eight nearly equal installments beginning on November 4, 2022.
Documents
Issuer
BioRestorative Therapies, Inc.
CIK 0001505497
Entity typeother
Related Parties
1- filerCIK 0001527241
Filing Metadata
- Form type
- 4
- Filed
- Oct 11, 8:00 PM ET
- Accepted
- Oct 12, 8:54 AM ET
- Size
- 19.9 KB